PRTAProthena Corporation plc

$512M

Q2 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$279,000-99.0% YoY

Gross Profit

-$31M-11173.1% margin

Operating Income

-$63M-22605.4% margin

Net Income

-$60M-21463.1% margin

EPS (Diluted)

$-1.50

QoQ Revenue Growth

+22.9%

Cash Flow

Operating Cash Flow

$58M

Free Cash Flow

$58M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$563M

Total Liabilities

$207M

Stockholders' Equity

$356M

Cash & Equivalents

$486M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$279,000	$27M	-99.0%
Gross Profit	-$31M	-$7M	-331.8%
Operating Income	-$63M	-$18M	-247.8%
Net Income	-$60M	-$18M	-238.3%

PRTA Q2 2018 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena